Dr. Jonathan N. Sellin, MD

Dr. Sellin practices at Medical Center Endoscopy in Houston, Texas.

Dr. Sellin's NPI, 1053625624, was assigned on August 5, 2010. Dr. Sellin graduated from New York University School of Medicine in 2010. Dr. Sellin holds Texas license R4470.

Dr. Sellin's primary practice is Medical Center Endoscopy, at 6560 Fannin Suite 600, Houston, TX 77030. The practice phone is (713) 790-1512.

Dr. Sellin's primary practice is Medical Center Endoscopy in Houston, Texas. Dr. Sellin is also affiliated with Houston Methodist Hospital. The medical group on file is Neurosurgical Group of Texas. Dmand AI also links Dr. Sellin to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sellin practices, 7 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Sellin's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Sellin is board certified in neurological surgery by the American Board of Neurological Surgery. Dr. Sellin is licensed in Texas.

Dmand AI lists back and neck pain treatment without fusion, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Sellin treats.

CMS data shows 798 Medicare services from Dr. Sellin across 18 procedure codes in 2024, for 254 Medicare patients. Medicare paid $225,592 for them.

CMS counts 254 Medicare patients who saw Dr. Sellin in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sellin's median patient age at 70, with 50% women.

In 2024, Dr. Sellin wrote 490 Medicare Part D claims for 170 patients. 100% of them were for generic drugs. CMS names the drug for 442 of them, across 7 drugs with 11 or more claims each, at $3,118 in total drug cost. In 2023, CMS named 316 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sellin for performance year 2024, reported as part of a group. Dr. Sellin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sellin as offering telehealth. CMS counts 464 procedures of spinal fusion by Dr. Sellin, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 36 papers to Dr. Sellin, published from 2010 to 2024. 2018 was the busiest year, with 7. The most frequent topics are Postoperative Complications, Spinal Neoplasms and Spinal Fusion. Dr. Sellin has published most often in J Neurosurg Spine. Dr. Sellin's most frequent co-authors are Claudio Esteves Tatsui, MD, Daniel H. Fulkerson, MD and Loyola V. Gressot.

CMS Open Payments shows 206 general payments to Dr. Sellin from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Alphatec Spine, Inc paid the most, $6,373.

Dr. Sellin graduated from New York University School of Medicine in 2010.

Dr. Sellin is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.